BofA/Merrill Lynch Downgrades Humana (HUM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/5/2026
- Dow, S&P 500 close at record on AI-linked earnings, Mideast deal hopes
- Caterpillar stock jumps on strong earnings and revenue beat
- Optical component stocks rally on proposed U.S. ban on Chinese tech
- BofA says this memory stock could double. Here are 5 reasons why
- Merck shares rise on big Q2 earnings beat, adjusted FY outlook
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Opendoor posts Q2 revenue rise as net loss widens year over year
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- Dave & Buster's names CFO Darin Harper as new CEO
- Dow, S&P 500 close at record on AI-linked earnings, Mideast deal hopes
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
Analysts Say Humana (HUM) Election Related Selloff Overdone
November 7, 2012 3:28 PM ESTAnalysts at Wedbush said they view today's sell-off in Human (NYSE: HUM) on election and related budget concerns as overdone.
"We believe rate pressure would exist in Medicare regardless of what political party is in power and that 5% margins are sustainable even with... More
Goldman Sachs Downgrades Humana (HUM) to Sell
November 7, 2012 8:09 AM ESTGoldman Sachs downgraded Humana (NYSE: HUM) from Neutral to Sell with a price target of $62.00 (from $77.00), suggesting 19% downside.
"With health reform now more likely to move ahead following the election outcome, we see greater downside risk to Medicare Advantage, which we estimate... More
